Sultana Shajahan

About Sultana Shajahan

PhD candidate

  • MD, MPH

Dr Sultana Shajahan is a final-year PhD candidate at The George Institute for Global Health and the University of New South Wales, Sydney. After completing her medical degree in Bangladesh, she earned a Master of Public Health (Research) degree with High Distinction at Macquarie University, Sydney.

Her doctoral research focuses on high-level evidence synthesis and advanced analyses of large international datasets (including ADVANCE, PROGRESS, and SCAPIS) to investigate how a wide range of clinically important blood pressure measures are associated with cognitive decline and dementia. This work aims to generate new insights to guide the design of future cohort studies and clinical trials targeting dementia prevention, a growing global health challenge. For her PhD research, she was awarded the Young Investigator Award at the European Stroke Organisation Conference (ESOC) in 2023.

Beyond her PhD, Dr Shajahan undertook a three-month international research exchange program at Linköping University, Sweden, funded by The Swedish National School for Research in General Practice. She was also a Site Physician in the recently completed RECALL-Pilot trial, which tested an online intervention to reduce dementia risk through blood pressure management. Previously, she gained extensive experience at The George Institute for Global Health, contributing to projects in stroke, women’s health, sex differences, and multimorbidity. She brings expertise and interest in systematic reviews, meta-analyses, clinical trials, cohort studies, blood pressure measurement, dementia prevention, cognition and stroke.

Associations of blood pressure parameters with cognitive decline and dementia: a systematic review of reviews

American Journal of Hypertension Date published:

Stages of hypertension and antihypertensive medication use in the brain health and memory clinic setting

Cerebrovascular Diseases Date published:

Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

Cerebral Circulation - Cognition and Behavior Date published:

Hypertension and Mild Cognitive Impairment: State-of-the-Art Review

American Journal of Hypertension Date published:

Related Readings